Ethyl 3,4-bis(2-methoxyethoxy)benzoate
- CAS No.183322-16-9
- GradeIndustrial / Pharmaceutical
- Availability● In Stock
High-purity Ethyl 3,4-Bis(2-Methoxyethoxy)Benzoate (CAS 183322-16-9) is a critical pharmaceutical intermediate designed for robust synthetic routes.
Request Bulk PricingProduct Technical Details
Product Overview
Our company specializes in the production and supply of high-quality fine chemicals, with a particular focus on advanced pharmaceutical intermediates. Ethyl 3,4-bis(2-methoxyethoxy)benzoate (CAS 183322-16-9) represents a key building block in modern organic synthesis. This compound is engineered to meet the rigorous demands of pharmaceutical manufacturing, ensuring consistency and reliability for downstream processes.
As a specialized chemical entity, this benzoate derivative features unique ether linkages that enhance its solubility and reactivity profiles. These characteristics make it an invaluable component for constructing complex molecular architectures required in targeted therapeutic development. Our manufacturing facilities adhere to strict quality management systems to guarantee that every batch meets specified purity standards.
Technical Specifications
We maintain transparent quality controls to support our partners in regulatory compliance and process optimization. The following table outlines the critical physical and chemical parameters verified during our quality assurance protocols.
| Parameter | Specification |
|---|---|
| CAS Number | 183322-16-9 |
| Molecular Formula | C15H22O6 |
| Molecular Weight | 298.33 g/mol |
| Appearance | White or off-white crystalline powder |
| Purity | ≥98.0% |
| Moisture Content | ≤0.5% |
| Impurity Level | ≤0.2% |
| Melting Point | 55-58°C |
| Boiling Point | 401.7°C at 760 mmHg |
| Density | 1.102 g/cm3 |
| Refractive Index | 1.488 |
Industrial Applications
This intermediate is primarily utilized in the synthesis of advanced pharmaceutical compounds. It serves as a crucial precursor in multi-step organic reactions, particularly within the domain of oncology therapeutic intermediates. The stability of the ether groups allows for versatile functionalization, enabling chemists to develop robust synthesis routes for active pharmaceutical ingredients.
Our clients leverage this material for process development, scale-up activities, and commercial manufacturing. The high purity level minimizes side reactions, thereby improving overall yield and reducing waste in production environments. We support various stages of drug development, from early-stage research to large-scale industrial production.
Quality Assurance And Packaging
Every shipment is accompanied by a comprehensive Certificate of Analysis (COA) detailing batch-specific test results. Our quality control laboratory employs advanced analytical techniques, including HPLC and NMR, to verify identity and purity. We are committed to providing technical support to assist with integration into your specific manufacturing processes.
Standard packaging consists of 25kg cardboard drums, designed to protect the material from moisture and physical damage during transit. Custom packaging solutions are available upon request to suit specific logistical requirements. We ensure all containers are well-closed and labeled according to international safety standards.
Storage And Handling
To maintain optimal stability, this product should be stored in a cool and dry environment. Containers must remain well-closed to prevent exposure to moisture, which could affect physical properties. It is recommended to keep the material away from strong light and heat sources. Proper handling procedures should be followed in accordance with local safety regulations and material safety data sheets.
Our global logistics network ensures timely delivery to partners worldwide. We prioritize secure shipping methods to guarantee that the product arrives in perfect condition. For bulk orders or long-term supply agreements, please contact our sales team for customized pricing and availability details.
